Estonia vs Sri Lanka: HIV/AIDS deaths averted by antiretroviral therapy
Estonia
217.74 deaths
in 2024
Sri Lanka
217.06 deaths
in 2024
Estonia rank
108th
Sri Lanka rank
109th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Estonia
- Sri Lanka
How they compare
Estonia currently reports 217.74 deaths against 217.06 deaths in Sri Lanka, a difference of 0.68 deaths.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Sri Lanka ahead.
Estonia ranks 108th and Sri Lanka ranks 109th of 157 countries.
Estonia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Estonia | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 76.25 deaths | 11.47 deaths | 64.78 deaths | Estonia |
| 2010s | 296.88 deaths | 86.12 deaths | 210.76 deaths | Estonia |
| 2020s | 240.39 deaths | 187.06 deaths | 53.32 deaths | Estonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Estonia or Sri Lanka?
- Estonia, at 217.74 deaths against 217.06 deaths in Sri Lanka as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Estonia and Sri Lanka?
- 0.68 deaths, with Estonia ahead.
- How many years of comparable data are there for Estonia and Sri Lanka?
- 35 years are reported by both, from 1990 to 2024.
- How do Estonia and Sri Lanka rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Estonia ranks 108th and Sri Lanka ranks 109th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.